EPLAW PATENT BLOG

DE – Merck Sharp & Dohme v. ratiopharm et al. / SPC / Appeal

Posted: March 28th, 2019

Higher Regional Court Düsseldorf, 15 March 2019, docket no. I-2 U 62/18 – Ezetimibe/Simvastatin On March 15, 2019 the Higher Regional Court Düsseldorf finally dismissed MSD’s request for a preliminary injunction based on their SPC for ezetimibe and simvastatin and thereby confirmed the result of the first instance decision of the Regional Court Düsseldorf of […]

READ MORE

DK – ELI LILLY V. MYLAN / THE DANISH MARITIME AND COMMERCIAL HIGH COURT (TADALAFIL)

Posted: March 14th, 2019

Eli Lilly and Company, ICOS Corporation, and Eli Lilly Danmark A/S (“Eli Lilly”) v. Generics (UK) Limited and Mylan AB (“Mylan”), the Danish Maritime and Commercial High Court, Case number BS-33415/2018-SHR, 1 February 2019 The case concerns infringement of Eli Lilly’s patent DK/EP 1 173 181 T6 (“DK/EP ‘181”) which relates to the use of […]

READ MORE

NL – F. Hoffmann-La Roche and Genentech v. Mundipharma

Posted: February 26th, 2019

F. Hoffmann-La Roche AG and Genentech Inc. v. Mundipharma Pharmaceuticals B.V., Judge in interlocutory proceedings, District Court The Hague, The Netherlands, 20 February 2019, ECLI:NL:RBDHA:2019:1486 Preliminary injunction proceedings re biosimilar. Hoffmann-La Roche and Genentech both are part of the Roche group. Genentech developed Herceptin® for the treatment of breast cancer, with the anti-HER2 antibody trastuzumab […]

READ MORE

DK – FRESENIUS KABI V. ELI LILLY (PEMETREXED)

Posted: February 21st, 2019

Fresenius Kabi AB v/Fresenius Kabi and Fresenius Kabi Oncology Plc. (“Fresenius Kabi”) v. Eli Lilly and Company and Eli Lilly Danmark A/S (“Lilly”), the Danish Eastern High Court, 20 December 2018, Case number B-2735-17 The case concerns the infringement of Lilly’s patent DK/EP 1 313 508 (“DK/EP ‘508”) which relates to the use of the […]

READ MORE

NL – Fast & Fluid Management v. Santint and Zhengzhou Sanhua Technology & Industry

Posted: February 15th, 2019

Fast & Fluid Management B.V. v. Santint B.V. and Zhengzhou Sanhua Technology & Industry Co., Ltd., Judge in interlocutory proceedings, District Court The Hague, The Netherlands, 8 February 2019, Case no. ECLI:NL:RBDHA:2019:1105 Fast & Fluid demanded a preliminary injunction against Santint and Zhengzhou due to alleged infringement on its EP 970 for a ‘valve assembly’. […]

READ MORE

UK – Novartis v. Dr. Reddy’s

Posted: February 5th, 2019

Novartis Pharmaceuticals UK Limited, Novartis Pharma AG & Novartis International Pharmaceutical AG v Dr. Reddy’s Laboratories (UK) Limited, UK Patents Court, 15 January 2019, [2018] EWHC 92 (Pat) In a recent case before the UK Patents Court, in addition to considering an application for summary judgment to revoke the patent in suit for added matter, […]

READ MORE

NL – Koninklijke Douwe Egberts v. Belmoca

Posted: January 30th, 2019

Koninklijke Douwe Egberts B.V. v. Belmoca BVBA, Interlocutory Judge of the District Court of The Hague, The Netherlands, 28 December 2018, Case No. ECLI:NL:RBDHA:2018:15453 Nespresso compatible coffee capsules. Koninklijke Douwe Egberts (hereafter: KDE) accuses Belmoca of indirect infringement of EP 521 relating to ‘A beverage preparation system, a capsule and a method for forming a […]

READ MORE

FR – Novartis v. Teva – Valsartan / Amlodipine – € 13,000,000 advance on damages

Posted: June 11th, 2018

Preliminary injunction issued by a French court against Teva’s generic of Novartis’ Exforge anti-hypertensive drug (valsartan/amlodipine) plus €13,000,000 awarded as an advance on damages On 7 June 2018, the tribunal de grande instance of Paris (Judge Marie Courboulay) issued a preliminary injunction against Teva’s generic of Novartis’ anti-hypertensive drug Exforge (valsartan/amlodipine) on the basis of […]

READ MORE

AT – Eli Lilly PI / Appeal

Posted: April 27th, 2018

Austrian Court of Appeals confirms PI based on equivalent infringement of Eli Lilly’s Alimta®-Patent In a decision of April 12th 2018, the Vienna Court of Appeals rejected an appeal against a preliminary injunction previously granted by the Vienna Commercial Court. The Court of Appeals confirmed that the offer or sale of a generic Pemetrexed product […]

READ MORE